BioXcel Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BTAI and other ETFs, options, and stocks.

About BTAI

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. 

CEO
Vimal D. Mehta
CEOVimal D. Mehta
Employees
37
Employees37
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2017
Founded2017
Employees
37
Employees37

BTAI Key Statistics

Market cap
35.79M
Market cap35.79M
Price-Earnings ratio
-0.15
Price-Earnings ratio-0.15
Dividend yield
Dividend yield
Average volume
716.12K
Average volume716.12K
High today
$1.49
High today$1.49
Low today
$1.45
Low today$1.45
Open price
$1.45
Open price$1.45
Volume
79.11K
Volume79.11K
52 Week high
$8.08
52 Week high$8.08
52 Week low
$1.17
52 Week low$1.17

Stock Snapshot

As of today, BioXcel Therapeutics(BTAI) shares are valued at $1.47. The company's market cap stands at 35.79M, with a P/E ratio of -0.15.

As of 2026-03-25, BioXcel Therapeutics(BTAI) stock has fluctuated between $1.45 and $1.49. The current price stands at $1.47, placing the stock +1.4% above today's low and -1.3% off the high.

BioXcel Therapeutics(BTAI) shares are trading with a volume of 79.11K, against a daily average of 716.12K.

In the last year, BioXcel Therapeutics(BTAI) shares hit a 52-week high of $8.08 and a 52-week low of $1.17.

In the last year, BioXcel Therapeutics(BTAI) shares hit a 52-week high of $8.08 and a 52-week low of $1.17.

People also own

Based on the portfolios of people who own BTAI. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.